Youmanitarian
12 Jun 2021
Biochemical Prostate Cancer Recurrence Post Surgery/RT
15 Views
TAKE ACTION
Donations would go to support charities for
#HEALTHCARE / Prostrate Cancer
Physicians provide clarity on how to treat prostate cancer recurrence following definitive therapy based on rapid prostate-specific antigen (PSA) doubling time and comment on what may be the role in Europe of apalutamide (Erleada) and enzalutamide (Xtandi) in the metastatic castration-resistant prostate cancer (M0 CRPC) space, based on the SPARTAN and PROSPER clinical trials.
Show more
More ways to take action
Explore ways that you can help bring a solution to this issue.
Create Youms with hashtags #HEALTHCARE
Create a challenge to bring awareness to this issue for people to complete
Create a fundraiser to support a charity that tackle this issue
Volunteer at charitable organization that support this cause
Create a movement page dedicated to this cause to bring awareness.
Start a uCharity for this cause and invite people to join it to support this cause
